Related Experiment Videos
Single-dose therapy for giardiasis in school-age children
Krisana Pengsaa1, Kriengsak Limkittikul, Chanathep Pojjaroen-anant
1Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. tmksp@mahidol.ac.th
Summary
A combination of albendazole and praziquantel showed a high cure rate for giardiasis in children, comparable to tinidazole. This combined therapy may also treat co-existing helminth infections.
Area of Science:
- * Infectious Diseases
- * Pediatric Parasitology
- * Clinical Pharmacology
Background:
- * Giardiasis is a common intestinal infection in school-age children.
- * Effective and safe treatment options are crucial for managing giardiasis and preventing its spread.
- * Investigating novel therapeutic combinations can improve treatment outcomes.
Purpose of the Study:
- * To evaluate the efficacy of a combined albendazole and praziquantel regimen for treating giardiasis in children.
- * To compare this combination therapy with single-agent albendazole and tinidazole treatments.
Main Methods:
- * A randomized controlled trial involving 84 school-age children with giardiasis.
- * Three treatment groups: albendazole-praziquantel combination, albendazole alone, and tinidazole alone.
- * Cure was defined as the absence of Giardia in two consecutive stool samples.
Main Results:
- * The albendazole-praziquantel combination achieved a parasitological cure rate of 74.2%.
- * Tinidazole showed the highest cure rate (92.6%), followed by the combination therapy.
- * Albendazole monotherapy had a cure rate of 50%. No significant difference was found between the combination and tinidazole groups.
Conclusions:
- * The combined albendazole-praziquantel regimen is a safe and potentially effective alternative for treating giardiasis in children.
- * This combination offers the advantage of treating concurrent helminth infections.
- * Further studies are needed to optimize the dosage of the combination therapy for Giardia intestinalis.